The US-Japan Medical Device Innovation Forum 2018 to Be Held in Shizuoka
The 5th Annual US-Japan Medical Device Innovation Forum will be held November 7 at Shizuoka Convention & Arts Center (GRANSHIP), Japan. This premier forum is expected to attract nearly 500 attendees from both the US and Japan, including internationally recognized experts. This year’s forum welcomes a true pioneer and visionary in the field of interventional cardiology, Dr. John B. Simpson.
The US-Japan Medical Device Innovation Forum has been held in Sendai 2014, Hiroshima 2015, Osaka 2016, Okinawa 2017, and, this year, Shizuoka 2018. The forum has grown steadily each year, and next year’s 6th Annual US-Japan Medical Device Innovation Forum is scheduled to take place in Kobe 2019.
Venue: Shizuoka Convention & Arts Center (GRANSHIP), Shizuoka Prefecture
US-Japan Experts from Medical Disciplines Converge
to Catalyze Innovation in Shizuoka
The US-Japan Medical Device Innovation Forum brings together experts from a range of medical disciplines, including Stanford University, Japan and US enterprises, medical personnel, and incubators/accelerators engaged in developing a core of medical device innovation. The forum features a series of panel discussions and lectures with successful case studies, presented by the experts so as to discuss challenges in the Japanese medical device business, outlook of medical device needs, adoption of effective R&D operations used in Silicon Valley a renowned frontrunner of emerging medical technology development transforming ideas into success, US-Japan collaborative solutions to resolve challenges, and other additional discussion.
This premier forum aims to drive continued growth of Japan’s medical device innovation, support to accelerate US-Japan collaboration, leverage Japan’s core competencies, and bring in new technologies to fill the gaps for infinite possibilities, that is to say, building “Global Ecosystems”.
- Name: US-JAPAN Medical Device Innovation Forum in SHIZUOKA 2018
- Date: Wednesday, November 7th, 2018
- Time: 9:00-18:00
- Languages: Japanese, English (Japanese-English simultaneous interpretation available)
- Venue: Shizuoka Convention & Arts Center (Granship), Conference Hall “Winds”
- Address: 2 Chome-3-1 Higashishizuoka Suruga-ku, Shizuoka-shi, Shizuoka-ken 422-8019, Japan (Google Map)
- Attendance Fee: Free
Note: For those who plan to attend Networking Reception (18:00-20:00), 5,000 yen is required at registration on the day
- Official Website: www.jp-us-mdif-2018.com (Japanese)
- US-Japan Medtech Frontiers
- 2018 US-Japan Medical Device Innovation Forum Shizuoka Executive Committee
- Terumo (Special Sponsorship)
- Hamamatsu Photonics
- Shizuoka Bank
- Hamamatsu Shinkin Bank
- Iwata Sinkin Bank
- Japan Products
Dr. John B. Simpson MD, PhD
Main Business Carreea
Chairman, US-Japan Medtech Frontiers
Jeff M. Trost
Venture Principal, Rock Health, Green Box Ventures
Founder and CEO, Japanese Organization for Medical Device Development
President and CEO, MT Healthcare Design Research
President and CEO, Johnan
Specially Appointed Associate Professor, Graduate School of Medicine and Faculty of Medicine, Osaka University
Board Member, US-Japan Medtech Frontiers
Program Director (U.S.)Japan Biodesign Stanford Biodesign
Director of Healthcare Section and Manager of Industrial Research Division, Development Bank of Japan Inc.
CDO Managing Executive Officer, SOMPO Holdings Group
Sawane Spring Co., Ltd.
Executive Officer and CTO Doctor of Science, Terumo Corporation
Regional Creation Strategy Promotion Center, Hamamatsu Shinkin Bank
Please register at the reception on the 11th floor by 8:50. (We will receive your business card.)
9:00 Opening Remarks
- Hirata Kawakatsu (Governor of Shizuoka Prefecture)
- Jack Moorman (Chairman, US-Japan Medtech Frontiers)
9:15 Lecture: What Made Silicon Valley Synonymous with Business Success? Vision of Future Medical Devices and Healthcare
Dr. John B. Simpson has revolutionized the field of medicine through innovations that have fundamentally altered how physicians treat cardiovascular disease. He invented and commercialized the first over-the-wire balloon catheter used for percutaneous transluminal coronary angioplasty (PTCA). Dr. Simpson’s unique approach to patient care and the success of less invasive interventional techniques, specifically PTCA, have generated a multi-disciplinary shift in medicine as ophthalmologists, radiologists, cardiologists, neurologists and surgeons alike have adopted this technique.
- Lecturer: John B. Simpson MD, PhD
- Introduction: Fumiaki Ikeno (Program Director (U.S.) Japan Biodesign, Stanford Biodesign)
9:50 Panel Discussion 1: Trends of Medical Devices “Digital Health, IoT, AR/VR, and Wearable” – Set to Change the Face of Healthcare
As the area of medical devices, e.g., digital health, IoT, connected health, AR/VR, and wearable, has been drastically expanding in recent years, the roles and boundaries of such devices may no longer be defined. In this panel discussion, we suggest methods of functionality-focused medical device development as well as potentials to deliver better healthcare services by analyzing data obtained via such medical devices, that will lead to better quality and lower cost of healthcare. Especially, the following three sectors are focused on: early diagnosis of disease; management care of chronic disease; and follow-up monitoring after acute disease incidence.
- Moderator: Jeff Trost (President & Founder, Voler Systems)
- Panelists: Walt Maclay (CEO, Voler Systems), Jim McDonnell (CEO, Kenzen) and Sam Yang (CEO, Kardian)
10:55 Panel Discussion 2: Japan’s Healthcare System Challenges
Japan seeks solutions to realize more sustainable and feasible healthcare systems, preparing for radical changes in society and healthcare, such as medical cost increases associated with age progression and implementation for advanced medical technology; and working-age population decline. The year 2018 becomes a landmark year as simultaneous revisions of medical service and long-term care fees have taken effect. In this panel discussion, we identify the challenges facing Japan and highlight the government measures as well as the best methods to address the issues in the industry.
- Moderator: Takahiro Uchida (Founder and CEO, Japanese Organization for Medical Device Development)
- Panelists: Tatsufumi Aoyama (Director of Healthcare Industry Office, Development Bank of Japan), Masamoto Yuhide (Director of Iizuka Hospital), Satoru Miyano (Director, Human Genome Analysis Center, Institute of Medical Science, The University of Tokyo) and Yamamoto Koji (Executive Officer, Social Welfare Executive Committee)
12:00 Panel Discussion 3: Outlooks of Development Needs in a Super-aged Society
Japan has the largest percentage of total population ages 65 and above in the world, and the US marks as the second largest. The incidence of chronic and aging diseases in seniors naturally rises. In both countries, the medical systems are well-developed, including medical treatments, and healthcare equipment and services. In this panel discussion, we focus on potential development needs and solutions along with the acceleration of a super-aged society.
- Moderator: Yasuko Akutsu (President and CEO, MT Healthcare Design Research)
- Panelists: Katsuya Iijima (Professor and Vice Director, Institute of Gerontology, The University of Tokyo), Koichi Narasaki (Managing Executive Officer, Sompo Holdings), and Kazuya Iijima (Professor, Institute of Advanced Aging Society, The University of Tokyo)
13:30 Luncheon Seminar
Introduction of Shizuoka’s Approach to Medical-Engineering Regional Collaboration:
- Seiji Yamamoto MD, PhD (Associate Professor, Education & Collaboration Department, Hamamatsu University School of Medicine)
- Katsunori Ueda (Director, Pharma Valley Center)
- Hiroaki Kasakawa (Executive Officer, Terumo)
- Kento Terada (Deputy Assistant Manager, Corporate Sales Department, Hamamatsu Shinkin Bank)
14:10 Panel Discussion 4: Boosting Innovation through SMEs
In this panel discussion, we identify challenges and obstacles to Japanese SMEs, entering foreign markets to develop business opportunities in medical device and healthcare industry. The US accounts for approximately 40% share of the medical device and healthcare market today and is the largest share worldwide. Through successful cases of Japanese SMEs in the US market, we discuss foreign market entry strategies.
- Moderator: Mitsuyo Yamamoto (President and CEO, Johnan)
- Panelists: Oki Sawane (Director of Manufacturing, Overseas Division, Sawane Spring), Yasuhiro Tsutsui (President and CEO, Tokai Medical Products), and Hayato Tomihara (Director, Medical and Welfare Equipment Industry Section, Ministry of Economy, Trade and Industry)
15:15 Panel Discussion 5: Building Global Ecosystems through the US-Japan Collaboration
Japan’s growth surge in incubators/accelerators, pitch contests, medical device R&D projects, and new medical device business establishments has been seen as active over the past five years. Although Japan’s ecosystems are still not at a mature stage of development yet, it goes without saying that collaboration with the US and other countries has played an important role in realizing this growth. In this panel discussion, we recognize the factors that have contributed to this tremendous growth and discuss methods to sustain it at strong level.
- Moderator: Masakazu Yagi (Specially Appointed Associate Professor, Graduate School of Medicine and Faculty of Medicine, Osaka University)
- Panelists: Daniel R. Burnett (Theranova, LLC), Aaron L. Berez MD (CEO, Alembic, LLC), Byung Ja “BJ” Ju (CEO, Incumedx), John Tsung-Chun Lee (National Taiwan University Hospital) and Atsihiro Nakagawa (Associate Professor, Tohoku University Hospital Clinical Research Promotion Center)
16:20 Panel Discussion 6: Best Practices of Business Collaboration between Japan and the US
In recent years, business collaboration has been vigorous between Japan and the US and has benefited many enterprises in both countries. In this panel discussion, we explain types of business collaboration, such as M&A (mergers and acquisitions) and cooperation, as well as discuss success stories and best practices of business collaboration in depth.
- Moderator: Kirk Zeller (Board Member, US-Japan Medtech Frontiers)
- Panelists: Joe Heanue (CEO, Triple Ring Technologies), Noriko Tojo (President and Representative Director of Otsuka Medical Device Co., Ltd.), and Brad Vale (Founding General Partner, Strategic Healthcare Investment Partners)
17:10 Closing Remarks
- Fumiaki Ikeno (Program Director (U.S.) Japan Biodesign, Stanford Biodesign)
17:30 Move to the Reception Room
- Participants moved to the 1001 conference room on the 10th floor (participation fee: 5,000 yen)
- Speakers and official officials take photos at the 11th floor
18:00 Networking Reception (Simultaneous holding: Regional company exhibition)
Opening remarks: 18:00
- Kyoji Nanba (Shizuoka prefecture deputy governor)
Closing remarks: 19:45
- Elton Satusky (Vice Chairman, WSGR Life Sciences Group, USJMF Board Member)
About the Venue – Shizuoka Prefecture
- Formulating a Cluster of Medical and Health Industries at the foot of Mount Fuji -
Image Source: Pharma Valley Center
Pharma Valley Project
Shizuoka boasts the greatest production value of pharmaceuticals and medical devices in all of Japan, and there are also many pharmaceutical, medical supply factories and research facilities in the eastern region area. In recent years, the accumulation of medical and health industries has advanced in Shizuoka, and the shipment value of chemicals and medical equipment is top class domestically.
In 2001, Shizuoka launched the Pharma Valley Project to develop a medical district / medical care in collaboration with residents, industry, academia, and government, castle-town centered around the Shizuoka Cancer Center.
The goal of the Pharma Valley Project is to strive to achieve the longest healthy living region of Japan, through “improving health standards and overcoming illnesses” and “establishing economic fundamentals for residents” with cutting-edge technology in the local industry. With a focus on vitalizing the region, developing the products, meeting the needs of patients and families, the project has led to positive results.
Full-fledged international conference facility “GRANSHIP”
Granship is a prefectural complex cultural facility established as “a base of cultural creation and exchange” by Shizuoka Prefecture. Conveniently located 3km from Shizuoka Station and adjacent to JR Higashi-Shizuoka Station, Granship is at the center of Shizuoka.
Since the fiscal year 2007, the Shizuoka Prefectural Cultural Foundation has been designated as an administrator of the grants from Shizuoka Prefecture and is engaged in activities such as grants-sponsored projects, rental projects, large-scale conventions, and various academic conferences.